Smoking and malignancy in sinonasal inverted papilloma

鼻息肉 鼻腔
作者
Sung-Lyong Hong,Bae-Hyun Kim,Junghoon Lee,Kyu-Sup Cho,Hwan-Jung Roh
出处
期刊:Laryngoscope [Wiley]
卷期号:123 (5): 1087-1091 被引量:29
标识
DOI:10.1002/lary.23876
摘要

Objectives/Hypothesis The authors investigated clinical features of squamous cell carcinomas (SCC) arising in sinonasal inverted papillomas (IP) and risk factors responsible for their malignant transformation. Study Design Retrospective analysis. Methods In total, 162 patients diagnosed with sinonasal IP and treated between 1998 and 2009 at Pusan National University Hospital were enrolled. Their demographic data, information about previous surgery, smoking history, treatment modalities, follow-up duration, recurrence, and presence of malignancy were reviewed retrospectively. Results Seventeen patients (10.5%) were diagnosed with SCC arising in sinonasal IPs. Among them, nine (9/162, 5.6%; 9/17, 52.9%) were diagnosed with synchronous malignancies and three (3/162, 1.8%; 3/17, 17.6%) were diagnosed with metachronous malignancies. In five cases (5/162, 3.1%; 5/17, 29.4%), we could not determine whether their malignancies were synchronous or metachronous. Among 53 smokers, 14 (26.4%) had malignant transformation, while only three (2.8%) in 109 nonsmokers had malignant transformation (Odds ratio = 12.7; P < .001). The mean follow-up in the 17 patients with malignancy was 47.0 months. Three patients did not receive surgical treatment and died of progression of SCC. Among the other 14 patients who underwent curative surgeries, four (28.6%) had recurrences, and their mean period to cancer recurrence was 6.3 months. Two of them died of progression of the cancer. Mean survival of the five patients who died was 14.0 months. They all belonged to T4 stage. Conclusions Smoking history is associated with malignant transformation of sinonasal IP. It suggests that close follow-up be required in smokers with sinonasal IP in order not to overlook the malignant transformation. Level of Evidence 2b.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zhz发布了新的文献求助10
刚刚
量子星尘发布了新的文献求助10
刚刚
科目三应助ytong采纳,获得10
刚刚
务实的以松完成签到,获得积分10
1秒前
赵正洁完成签到 ,获得积分10
1秒前
嘘嘘发布了新的文献求助10
2秒前
2秒前
科研通AI6.1应助sanyiwen采纳,获得10
3秒前
3秒前
科研通AI6.3应助Tian采纳,获得30
4秒前
孤云完成签到,获得积分10
4秒前
韦鑫龙发布了新的文献求助30
4秒前
可爱的函函应助木康薛采纳,获得10
4秒前
ZQ完成签到,获得积分10
5秒前
5秒前
Don完成签到 ,获得积分10
5秒前
yuyuan完成签到,获得积分10
5秒前
5秒前
5秒前
6秒前
6秒前
涛浪完成签到,获得积分20
6秒前
6秒前
核动力驴发布了新的文献求助10
7秒前
无花果应助科研通管家采纳,获得30
7秒前
liushikai应助科研通管家采纳,获得20
7秒前
无极微光应助科研通管家采纳,获得20
7秒前
7秒前
乐乐应助科研通管家采纳,获得10
7秒前
充电宝应助科研通管家采纳,获得10
7秒前
爆米花应助科研通管家采纳,获得10
7秒前
香蕉觅云应助科研通管家采纳,获得10
7秒前
7秒前
笑柳应助科研通管家采纳,获得10
8秒前
汉堡包应助科研通管家采纳,获得10
8秒前
每念至此完成签到,获得积分10
8秒前
8秒前
Lucas应助科研通管家采纳,获得10
8秒前
852应助科研通管家采纳,获得10
8秒前
赘婿应助科研通管家采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Principles of town planning : translating concepts to applications 500
Short-Wavelength Infrared Windows for Biomedical Applications 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6060555
求助须知:如何正确求助?哪些是违规求助? 7893011
关于积分的说明 16304041
捐赠科研通 5204631
什么是DOI,文献DOI怎么找? 2784484
邀请新用户注册赠送积分活动 1767031
关于科研通互助平台的介绍 1647334